These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20726956)

  • 21. Validation of a haemoglobin dilution method for estimation of blood loss.
    Meunier A; Petersson A; Good L; Berlin G
    Vox Sang; 2008 Aug; 95(2):120-4. PubMed ID: 18510580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of capillary hemoglobin screening under routine conditions.
    Ziemann M; Lizardo B; Geusendam G; Schlenke P
    Transfusion; 2011 Dec; 51(12):2714-9. PubMed ID: 21599674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of hemoglobin levels in whole blood donors: how to model donation history.
    Baart AM; Vergouwe Y; Atsma F; Moons KG; de Kort WL
    Transfusion; 2014 Mar; 54(3 Pt 2):925-32. PubMed ID: 24111811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation and updating of a Dutch prediction model for low hemoglobin deferral in Irish whole blood donors.
    Baart AM; Atsma F; McSweeney EN; Moons KG; Vergouwe Y; de Kort WL
    Transfusion; 2014 Mar; 54(3 Pt 2):762-9. PubMed ID: 23607909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models.
    Nasserinejad K; de Kort W; Baart M; Komárek A; van Rosmalen J; Lesaffre E
    BMC Med Res Methodol; 2013 May; 13():62. PubMed ID: 23635008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The consequences of temporary deferral on future whole blood donation.
    Custer B; Chinn A; Hirschler NV; Busch MP; Murphy EL
    Transfusion; 2007 Aug; 47(8):1514-23. PubMed ID: 17655597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of whole-blood donors for hemoglobin testing by use of historical hemoglobin values.
    Ziemann M; Steppat D; Brockmann C; Washington G; Kirchner H; Schlenke P
    Transfusion; 2006 Dec; 46(12):2176-83. PubMed ID: 17176332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A noninvasive strategy for screening prospective blood donors for anemia.
    Lotfi R; Wernet D; Starke U; Northoff H; Cassens U
    Transfusion; 2005 Oct; 45(10):1585-92. PubMed ID: 16181209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of risk-dependent interventions on low haemoglobin deferral rates in whole blood donors.
    Baart AM; van den Hurk K; de Kort WLAM; Huis In 't Veld EMJ
    Vox Sang; 2020 Apr; 115(3):171-181. PubMed ID: 31912518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of nucleated cells in bone marrow stem cell products by donor characteristics: a retrospective single centre analysis.
    Bouwmeester W; Fechter MM; Heymans MW; Twisk JW; Ebeling LJ; Brand A
    Vox Sang; 2010 Apr; 98(3 Pt 1):e276-83. PubMed ID: 19951308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of conversion from blood donation to plasma donation on serum ferritin and hemoglobin].
    Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
    Tidsskr Nor Laegeforen; 1991 Jan; 111(2):189-90. PubMed ID: 1998176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study.
    Bell S; Sweeting M; Ramond A; Chung R; Kaptoge S; Walker M; Bolton T; Sambrook J; Moore C; McMahon A; Fahle S; Cullen D; Mehenny S; Wood AM; Armitage J; Ouwehand WH; Miflin G; Roberts DJ; Danesh J; Di Angelantonio E;
    Transfus Med; 2021 Apr; 31(2):94-103. PubMed ID: 33341984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron and blood donation- an under-recognised safety issue.
    Farrugia A
    Dev Biol (Basel); 2007; 127():137-46. PubMed ID: 17486886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply.
    Vinkenoog M; van Leeuwen M; Janssen MP
    Vox Sang; 2022 Nov; 117(11):1262-1270. PubMed ID: 36102148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and reasons of donor deferral prior to blood donation process: a single centre experience.
    Khurram S; Borhany M; Anwar N; Naseer I; Boota S; Mirza I; Nadeem M; Shamsi T
    Transfus Med; 2017 Feb; 27(1):10-15. PubMed ID: 27730692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collection of autologous blood for bone marrow donation: how useful is it?
    Parkkali T; Juvonen E; Volin L; Partanen J; Ruutu T
    Bone Marrow Transplant; 2005 Jun; 35(11):1035-9. PubMed ID: 15821763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle behaviours, ethnicity and menstruation have little added value in prediction models for low haemoglobin deferral in whole blood donors.
    Baart AM; Timmer T; de Kort WLAM; van den Hurk K
    Transfus Med; 2020 Feb; 30(1):16-22. PubMed ID: 31782196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of blood donation frequency on iron status.
    Røsvik AS; Ulvik RJ; Wentzel-Larsen T; Hervig T
    Transfus Apher Sci; 2009 Dec; 41(3):165-9. PubMed ID: 19819187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.